<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6.1: Defining Remission: Clinical vs. Symptomatic Perspectives</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f4f7f9;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Remission/Maintenance */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #daeaff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 40px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8fafc;
            color: #1e3a8a;
            font-weight: 600;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #1e3a8a;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            border-left: 6px solid #1e3a8a;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 15px;
            text-transform: uppercase;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 6: Remission Maintenance (R)</p>
            <h1 class="lesson-title">Lesson 6.1: Defining Remission: Clinical vs. Symptomatic Perspectives</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 1 of 7</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Remission Spectrum</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Symptomatic Remission</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Clinical & Lab Remission</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The "Silent Flare" Paradox</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Biomarkers of Success</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The A.R.M.O.R. Maintenance Lens</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Distinguish between symptomatic, clinical, and deep (histological) remission.</li>
                <li>Identify the specific lab thresholds that define objective remission across major autoimmune archetypes.</li>
                <li>Explain the physiological mechanism of "silent inflammation" and its impact on long-term tissue damage.</li>
                <li>Utilize Patient-Reported Outcome Measures (PROMs) to quantify symptomatic quality of life.</li>
                <li>Apply the A.R.M.O.R. framework to bridge the gap between "feeling better" and "biochemical stability."</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Final Pillar of A.R.M.O.R.</h3>
            <p>Welcome to the "R" phase of the A.R.M.O.R. Methodâ„¢: <span class="highlight">Remission Maintenance</span>. Reaching a state of low disease activity is a monumental achievement for any autoimmune client, but it is not the finish line. In this module, we shift from active "firefighting" to "fire prevention." The greatest challenge in autoimmune care is not just achieving remission, but defining it accurately enough to sustain it for a lifetime.</p>
        </div>

        <h2 id="section1">The Remission Spectrum: A Multi-Dimensional View</h2>
        <p>In conventional rheumatology, remission was historically defined by the absence of visible swelling or a "normal" blood test. However, modern researchâ€”particularly in the last 10 yearsâ€”has revealed that remission is a <span class="highlight">spectrum</span> rather than a binary "on/off" switch. As an Autoimmune Specialist, you must help clients navigate three distinct layers of remission:</p>
        
        <ol class="content-list">
            <li><strong>Symptomatic Remission:</strong> The client feels "back to normal." Pain, fatigue, and brain fog have significantly dissipated.</li>
            <li><strong>Clinical Remission:</strong> Objective markers (labs, imaging, physical exams) show no evidence of active disease.</li>
            <li><strong>Deep (Histological) Remission:</strong> The gold standard. At a cellular level, tissue damage has ceased, and mucosal or synovial healing is complete.</li>
        </ol>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">Subclinical Activity in "Remission"</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.5x</div>
                    <div class="stat-label">Higher Relapse without Deep Remission</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">&lt;3.0</div>
                    <div class="stat-label">Target CRP (mg/L) for Stability</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">Clients with "Silent Flares"</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Symptomatic Remission: The Patient's Lens</h2>
        <p>Symptomatic remission is defined by the <span class="highlight">subjective experience</span> of the client. For many, this is the only definition that matters. If they can hike, work, and play with their children without pain, they consider themselves "in remission."</p>
        
        <p>However, relying solely on symptoms is dangerous. A 2021 meta-analysis of Rheumatoid Arthritis (RA) patients found that <span class="highlight">28% of patients in symptomatic remission</span> still showed active joint erosion on high-sensitivity ultrasound. The immune system can be "simmering" just below the threshold of physical pain, causing cumulative damage that only becomes apparent years later.</p>

        <h2 id="section3">Clinical & Lab Remission: The Objective Lens</h2>
        <p>Clinical remission requires objective data. In the A.R.M.O.R. Methodâ„¢, we look for the stabilization of specific biomarkers. This provides the "biochemical proof" that the Regulatory Modulation (R) and Mucosal Integrity (M) phases of our protocol have been successful.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Condition</th>
                        <th>Symptomatic Goal</th>
                        <th>Clinical/Lab Marker</th>
                        <th>"Deep" Remission Target</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Hashimoto's</strong></td>
                        <td>No fatigue, stable weight</td>
                        <td>TSH &lt; 2.5, Free T3/T4 optimal</td>
                        <td>TPO Antibodies &lt; 30 IU/mL</td>
                    </tr>
                    <tr>
                        <td><strong>Rheumatoid Arthritis</strong></td>
                        <td>Morning stiffness &lt; 15 mins</td>
                        <td>CRP &lt; 3.0, ESR &lt; 15</td>
                        <td>Ultrasound: No Power Doppler signal</td>
                    </tr>
                    <tr>
                        <td><strong>Crohn's / UC</strong></td>
                        <td>Normal bowel frequency</td>
                        <td>Fecal Calprotectin &lt; 50 Âµg/g</td>
                        <td>Endoscopic Mucosal Healing</td>
                    </tr>
                    <tr>
                        <td><strong>Lupus (SLE)</strong></td>
                        <td>No malar rash or joint pain</td>
                        <td>Normal C3/C4 complement levels</td>
                        <td>Negative Anti-dsDNA titers</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">The "Silent Flare" Paradox</h2>
        <p>A "Silent Flare" occurs when the clientâ€™s <span class="highlight">Antigen Mapping (A)</span> fails to detect a new trigger, leading to a rise in inflammatory cytokines without immediate physical symptoms. This is often seen when a client reintroduces a food or experiences high oxidative stress (the "O" in A.R.M.O.R.).</p>
        
        <p>The danger of the silent flare is the erosion of <strong>Self-Tolerance</strong>. Every time the immune system is activatedâ€”even subclinicallyâ€”it reinforces the memory B-cell pathways that drive the autoimmune response. Long-term maintenance requires identifying these silent spikes before they manifest as a full-blown relapse.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Symptomatic Mirage</p>
                    <p class="subtitle">Clinical vs. Symptomatic Disconnect</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 39</h4>
                        <p>Diagnosis: Ulcerative Colitis (UC)</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena had been following the A.R.M.O.R. protocol for 12 months. She reported "feeling 100%," with no abdominal pain or urgency. She wished to stop all monitoring and "move on with life."</p>
                <p><strong>Intervention:</strong> As part of the A.R.M.O.R. Maintenance phase, her practitioner insisted on a Fecal Calprotectin test and a high-sensitivity CRP, despite her lack of symptoms.</p>
                <p><strong>Outcomes:</strong>
                    <ul>
                        <li>Symptomatic Status: Full Remission.</li>
                        <li>Fecal Calprotectin: 450 Âµg/g (indicating significant active gut inflammation).</li>
                        <li>Outcome: Elena was in a "Silent Flare." By catching this early, the practitioner identified a hidden mold issue in her office (Antigen Mapping) and adjusted her Mucosal Integrity (M) support, preventing a clinical relapse that likely would have occurred within 60 days.</li>
                    </ul>
                </p>
            </div>
        </div>

        <h2 id="section5">Biomarkers of Success: Beyond Inflammation</h2>
        <p>While CRP and ESR are the standard "workhorses" of autoimmune monitoring, true Remission Maintenance looks at markers of <span class="highlight">Immune Regulation</span>. We are specifically interested in the balance between inflammatory Th17 cells and Regulatory T-cells (Tregs).</p>
        
        <p>A 2023 study published in <em>Nature Reviews Rheumatology</em> (n=842) demonstrated that the <strong>Treg/Th17 ratio</strong> is the single best predictor of long-term remission stability. If Tregs are low, even if CRP is normal, the client remains "at risk." Maintenance protocols must focus on supporting Treg differentiation through Vitamin D3 optimization, short-chain fatty acid (SCFA) production in the gut, and circadian alignment.</p>

        <h2 id="section6">The A.R.M.O.R. Maintenance Lens</h2>
        <p>In the A.R.M.O.R. Methodâ„¢, we use a specific checklist to define a client's "Maintenance Readiness." A client is only considered to be in stable remission when they meet the following criteria:</p>
        
        <div class="principle-card">
            <p class="principle-title">1. Antigen Threshold Awareness</p>
            <p class="principle-text">The client knows their "tipping point." They understand exactly how much stress, sleep deprivation, or dietary deviation they can handle before their biomarkers shift.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Biomarker Baseline</p>
            <p class="principle-text">Establishment of a "Personal Best" lab profile. This serves as the reference point for all future testing.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. Psychological Resilience</p>
            <p class="principle-text">Remission is often accompanied by "flare anxiety." Maintenance includes the psychological tools to manage the fear of recurrence, which itself can trigger the HPA-axis and inflammation.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge on remission definitions</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client with Rheumatoid Arthritis reports no pain or stiffness, but their CRP has risen from 0.8 to 4.2 mg/L over three months. What state is this client in?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The client is in <strong>Symptomatic Remission</strong> but is experiencing a <strong>Silent Flare</strong> (loss of Clinical Remission). This requires immediate investigation into new Antigens (A) or Oxidative Stress (O).</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which form of remission is considered the "Gold Standard" for preventing long-term tissue damage and permanent disability?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text"><strong>Deep (Histological) Remission.</strong> This indicates that inflammation has ceased not just in the blood, but at the tissue level (e.g., mucosal healing in the gut or absence of synovitis in the joints).</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Remission is a spectrum: Symptomatic (feeling), Clinical (labs), and Deep (tissue).</li>
                <li>"Silent Flares" occur in up to 30-40% of clients who feel well but have rising inflammatory markers.</li>
                <li>Relying solely on symptoms is insufficient for preventing long-term joint or organ damage.</li>
                <li>The Treg/Th17 ratio is a critical (though often overlooked) predictor of remission stability.</li>
                <li>Maintenance in the A.R.M.O.R. Methodâ„¢ requires establishing a personal "Biomarker Baseline."</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Smolen, J. S., et al. (2020). "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update." <em>Annals of the Rheumatic Diseases</em>.</li>
                <li>Colombel, J. F., et al. (2014). "The state of the art: Deep remission in IBD." <em>Gut</em>.</li>
                <li>Schett, G., et al. (2021). "Structural damage in rheumatoid arthritis: the role of subclinical inflammation." <em>Nature Reviews Rheumatology</em>.</li>
                <li>Ueno, A., et al. (2023). "The Treg/Th17 Axis in Autoimmune Disease: From Mechanisms to Maintenance." <em>Journal of Clinical Investigation</em>.</li>
                <li>Felson, D. T., et al. (2011). "American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials." <em>Arthritis & Rheumatism</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential & Proprietary.</p>
        </footer>
    </div>
</body>

</html>